Ozempic & Carnaval: Risks of Alcohol & Heat for Weight Loss Drug Users

Health officials are warning individuals using glucagon-like peptide-1 (GLP-1) medications, such as Mounjaro and Ozempic, to exercise caution during Carnival celebrations. While there is no formal prohibition against alcohol consumption for those on these drugs, the convergence of factors common during the festivities – including alcohol intake, high temperatures, fasting, and dehydration – can elevate the risk of adverse health effects.

The concerns center around the potential for increased discomfort, hypoglycemia, and other metabolic complications. Carnival, with its extended periods of exposure to intense heat, irregular hydration, prolonged fasting due to event participation, and concentrated alcohol consumption, creates a scenario that could amplify the negative effects of these medications.

Cynthia Valério, director of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) and subcoordinator of the Department of Obesity at the Brazilian Society of Endocrinology and Metabolism (SBEM), stated that there is “no formal contraindication to alcohol consumption,” but recommended “greater moderation” for individuals using GLP-1 drugs.

The warning comes amid growing scrutiny of GLP-1 medications, which have gained popularity for weight loss. Recent reports have highlighted the circulation of counterfeit versions of drugs like Mounjaro and Ozempic, posing severe health risks to consumers. The U.S. Food and Drug Administration (FDA) has been urged to crack down on these fake medications, which may contain undisclosed ingredients or incorrect dosages.

GLP-1 receptor agonists work by mimicking the effects of the naturally occurring GLP-1 hormone, which regulates appetite and blood sugar levels. While effective for weight management and diabetes control, these drugs can cause side effects such as nausea, vomiting, and diarrhea. Combining these side effects with the dehydrating effects of alcohol and the physical demands of Carnival could exacerbate health risks.

Health professionals emphasize that individuals using GLP-1 medications should remain well-hydrated, maintain regular meal schedules as much as possible, and limit alcohol intake during Carnival. Those experiencing any symptoms of hypoglycemia, such as dizziness, confusion, or sweating, should seek immediate medical attention.